Reversible decrease in swimming motility accompanies emergent β-lactam antibiotic resistance in Escherichia coli
- 1NIST
Abstract
Antimicrobial resistance (AMR) threatens global health, food security, and development; however, the evolutionary and molecular pathways that drive AMR remain poorly understood, limiting our ability to advance diagnostics and rapidly detect newly emerging resistance. In this report, we employed laboratory evolution of an environmental Escherichia coli strain (NIST 0056) under B-lactam antibiotic pressure (ampicillin and cephalexin) to specifically investigate the relationship between resistance genotype and motility phenotype. Within 10 passages, populations evolved varying levels of B-lactam resistance (including high-level resistance > 32 ug/mL) and showed consistent, dose-dependent reductions in swimming motility. Whole-population genome sequencing revealed large deletions in marR, SNPs in efflux pump gene acrB and fumarate reductase gene frdD, and mutations with evidence of amplification in the chromosomal class C B-lactamase gene ampC, collectively linking these efflux-mediated, B-lactam resistance mechanisms to loss of motility. Notably, motility reductions were more pronounced in individual clones than in the mixed populations (p < 0.005, Mann-Whitney; two-tailed test). Following removal of antibiotic pressure, motility was restored and AMR-associated mutations decreased in frequency, suggesting fitness costs associated with resistance. In aggregate, our results demonstrate that reduced swimming motility accompanies specific efflux-driven, B-lactam resistance mechanisms. Further work will investigate if the behavior is generalizable across flagellated Enterobacteriaceae. Because these rapid changes are amenable to high-throughput measurement, swimming motility may offer a tractable physiological metric for AMR detection in environmental surveillance.
Related
- Drainage water management reduces nutrient, Escherichia coli, and antibiotic resistance gene export
- Hybrid sequencing of chromosome and plasmids from multidrug-resistant Escherichia coli isolated in Cambodia: Are megaplasmids vectors of antibiotic resistance genes?
- Shared Resistance, Phage-Receptor, and Biofilm Determinants in Antibiotic-Resistant Pseudomonas aeruginosa, Escherichia coli, and Acinetobacter baumannii: A Bibliometric and Gene-Network Analysis of Phage Cocktail Research.
- Genomic insight into the antibiotic-resistant determinants of Escherichia coli from small ruminants and manure in North West Province, South Africa
- Response to comment on “Using genomic data and machine learning to predict antibiotic resistance: A tutorial paper”
BibTeX
@misc{stabryla2026reversible,
title = {{Reversible decrease in swimming motility accompanies emergent β-lactam antibiotic resistance in Escherichia coli}},
author = {L. Stabryla and W. Ackerman and J. N. Dootz and S. L. Servetas and S. A. Jackson and J. G. Kralj},
howpublished = {bioRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.06.764950},
url = {https://www.biorxiv.org/content/10.64898/2026.11.06.764950v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Reversible decrease in swimming motility accompanies emergent β-lactam antibiotic resistance in Escherichia coli
AU - L. Stabryla
AU - W. Ackerman
AU - J. N. Dootz
AU - S. L. Servetas
AU - S. A. Jackson
AU - J. G. Kralj
PY - 2026
DA - 2026/11/06
PB - bioRxiv
DO - 10.64898/2026.11.06.764950
UR - https://www.biorxiv.org/content/10.64898/2026.11.06.764950v1
AB - Antimicrobial resistance (AMR) threatens global health, food security, and development; however, the evolutionary and molecular pathways that drive AMR remain poorly understood, limiting our ability to advance diagnostics and rapidly detect newly emerging resistance. In this report, we employed laboratory evolution of an environmental Escherichia coli strain (NIST 0056) under B-lactam antibiotic pressure (ampicillin and cephalexin) to specifically investigate the relationship between resistance genotype and motility phenotype. Within 10 passages, populations evolved varying levels of B-lactam resistance (including high-level resistance > 32 ug/mL) and showed consistent, dose-dependent reductions in swimming motility. Whole-population genome sequencing revealed large deletions in marR, SNPs in efflux pump gene acrB and fumarate reductase gene frdD, and mutations with evidence of amplification in the chromosomal class C B-lactamase gene ampC, collectively linking these efflux-mediated, B-lactam resistance mechanisms to loss of motility. Notably, motility reductions were more pronounced in individual clones than in the mixed populations (p < 0.005, Mann-Whitney; two-tailed test). Following removal of antibiotic pressure, motility was restored and AMR-associated mutations decreased in frequency, suggesting fitness costs associated with resistance. In aggregate, our results demonstrate that reduced swimming motility accompanies specific efflux-driven, B-lactam resistance mechanisms. Further work will investigate if the behavior is generalizable across flagellated Enterobacteriaceae. Because these rapid changes are amenable to high-throughput measurement, swimming motility may offer a tractable physiological metric for AMR detection in environmental surveillance.
ER -